Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Baxter
Merck
AstraZeneca
Dow
Boehringer Ingelheim
Harvard Business School

Last Updated: December 7, 2019

DrugPatentWatch Database Preview

AXID AR Drug Profile

See Plans and Pricing

« Back to Dashboard

Which patents cover Axid Ar, and when can generic versions of Axid Ar launch?

Axid Ar is a drug marketed by Pfizer and is included in one NDA.

The generic ingredient in AXID AR is nizatidine. There are seven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the nizatidine profile page.

Drug patent expirations by year for AXID AR
Recent Litigation for AXID AR

Identify potential future generic entrants

District Court Litigation
Case NameDate
Baker v. Pfizer, Inc.2010-05-04
Sunovion Pharmaceuticals v. Dey Pharma2006-02-22

See all AXID AR litigation

Synonyms for AXID AR
(E)-1-N'-[2-[[2-(dimethylaminomethyl)-1,3-thiazol-4-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine
(E)-N-(2-(((2-((dimethylamino)methyl)thiazol-4-yl)methyl)thio)ethyl)-N'-methyl-2-nitroethene-1,1-diamine
(E)-N-(2-((2-((dimethylamino)methyl)thiazol-4-yl)methylthio)ethyl)-N-methyl-2-nitroethene-1,1-diamine
(E)-N-[2-[[2-(dimethylaminomethyl)-1,3-thiazol-4-yl]methylsulfanyl]ethyl]-N'-methyl-2-nitroethene-1,1-diamine
(E)-N-{2-[({2-[(dimethylamino)methyl]-1,3-thiazol-4-yl}methyl)thio]ethyl}-N'-methyl-2-nitroethene-1,1-diamine
(E)-N1'-[2-[[2-[(dimethylamino)methyl]-1,3-thiazol-4-yl]methylsulfanyl]ethyl]-N1-methyl-2-nitro-ethene-1,1-diamine
(E)-N1'-[2-[[2-[(dimethylamino)methyl]-4-thiazolyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine
1,1-Ethenediamine, N-(2-(((2-((dimethylamino)methyl)-4-thiazoly)methyl)thio)ethyl)-N'-methyl-2-nitro-
1,1-Ethenediamine, N-(2-(((2-((dimethylamino)methyl)-4-thiazolyl)methyl)thio)ethyl)-N'-methyl-2-nitro-
1,1-ethenediamine, n-[2-[[[2-[(dimethylamino)methyl]-4-thiazolyl]methyl]thio]ethyl]-n'-methyl-2-nitro-
1,1-Ethenediamine, N'-[2-[[[2-[(dimethylamino)methyl]-4-thiazolyl]methyl]thio]ethyl]-N-methyl-2-nitro-
76963-41-2
963N412
A838919
AB00698253_09
AB00698253-07
AB0106214
AB2000352
AC-5272
AC1MHW19
AC1Q1WQW
AC1Q40UA
Acinon
Acinon (TN)
AK546856
AKOS015900643
Antizid
Axid
Axid (TN)
BIDD:GT0761
BRD-K73589491-001-05-4
BRD-K92193792-001-01-7
BRN 4846056
C07270
C12H21N5O2S2
Calmaxid
CAS-76963-41-2
CCG-100836
CHEBI:7601
CHEMBL653
CPD000466384
Cronizat
CS-2350
D00440
DB00585
dimethyl[(4-{[(2-{[(E)-1-(methylamino)-2-nitroethenyl]amino}ethyl)sulfanyl]methyl}-1,3-thiazol-2-yl)methyl]amine
dimethyl[(4-{[(2-{[1-(methylamino)-2-nitroethenyl]amino}ethyl)sulfanyl]methyl}-1,3-thiazol-2-yl)methyl]amine
Distaxid
EBD34008
Galitidin
Gastrax
GTPL7248
HMS2051K04
HMS2094A15
HMS2235N05
HS-0083
HSDB 3574
HY-B0310
I14-0503
L000761
LS-67650
LY 139037
LY-139037
LY-139037, Nizatidine
MLS000759518
MLS001076680
MLS001424001
MolPort-003-849-605
MolPort-027-655-252
N-(2-(((2-((Dimethylamino)methyl)-4-thiazolyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine
N-(4-(6-Methylamino-7-nitro-2-thia-5-aza-6-hepten-1-yl)-2-thiazolylmethyl)-N,N-dimethylamin
N-(4-(6-Methylamino-7-nitro-2-thia-5-aza-6-hepten-1-yl)-2-thiazolylmethyl)-N,N-dimethylamine
N-{2-[({2-[(dimethylamino)methyl]-1,3-thiazol-4-yl}methyl)sulfanyl]ethyl}-N'-methyl-2-nitroethene-1,1-diamine
Naxidine
NC00086
NCGC00016934-01
NCGC00016934-02
NE47126
Niatidine
Niaztidine
Nizatidina
Nizatidina [Spanish]
nizatidine
Nizatidine (JP17/USP/INN)
Nizatidine [USAN:BAN:INN:JAN]
Nizatidine-d3
Nizatidine, analytical standard
Nizatidinum
Nizatidinum [Latin]
Nizax
Nizaxid
NSC-759289
NSC759289
Panaxid
Pharmakon1600-01505985
Prestwick2_000921
SAM001246752
SBI-0206937.P001
SC-15260
SCHEMBL769
SCHEMBL770
SGXXNSQHWDMGGP-IZZDOVSWSA-N
SMR000466384
Splendil ER
SR-01000765410
SR-01000765410-4
Tazac
Tazac;Axid;Axid AR
Ulcosol
Ulxid
Zanizal
ZE-101
ZINC1530736
Zinga
ZL-101

US Patents and Regulatory Information for AXID AR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer AXID AR nizatidine TABLET;ORAL 020555-001 May 9, 1996 OTC Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Medtronic
Mallinckrodt
Colorcon
McKinsey
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.